Literature DB >> 1763730

Subacute necrotizing myelopathy: MR imaging in four pathologically proved cases.

D R Mirich1, W Kucharczyk, M A Keller, J Deck.   

Abstract

This report describes the MR and correlative imaging findings of four histologically proved cases of subacute necrotizing myelopathy in which there was no evidence of a spinal dural arteriovenous fistula. Subacute necrotizing myelopathy is characterized clinically by progressive motor and sensory deterioration, and pathologically by necrosis in the spinal cord. Initial MR imaging showed focal enlargement of the spinal cord and nonspecific T1 and T2 lengthening. Rimlike enhancement was demonstrated in one case. Clinically, steroid therapy failed in all four patients. Follow-up MR scans showed two slightly enlarged lesions, one stable thoracolumbar lesion, and atrophy of a cervical lesion. Open spinal cord biopsies revealed foci of necrosis and abnormal parenchymal vessels with thickened hyalinized walls. A prolonged course distinguishes subacute necrotizing myelopathy from acute transverse myelitis, but the clinical course and imaging appearance are similar to those of intramedullary tumor. Rimlike rather than solid contrast enhancement may be a distinguishing feature. In the absence of a demonstrable spinal dural arteriovenous fistula, the radiologic differentiation of subacute necrotizing myelopathy from tumor is probably impossible, and biopsy establishes the correct diagnosis.

Entities:  

Mesh:

Year:  1991        PMID: 1763730      PMCID: PMC8331482     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  5 in total

Review 1.  Non-neoplastic intramedullary pathology. Diagnostic dilemma: to Bx or not to Bx.

Authors:  T H Schwartz; P C McCormick
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

2.  Reversible aggravation of neurological deficits after steroid medication in patients with venous congestive myelopathy caused by spinal arteriovenous malformation.

Authors:  C-S Lee; H W Pyun; E Y Chae; K-K Kim; S C Rhim; D C Suh
Journal:  Interv Neuroradiol       Date:  2009-11-04       Impact factor: 1.610

3.  Histologically proven venous congestive myelopathy without concurrent vascular malformation: Case reports and review of the literature.

Authors:  Teppei Matsubara; Hiroyoshi Akutsu; Shinya Watanabe; Kei Nakai; Satoshi Ayuzawa; Akira Matsumura
Journal:  Surg Neurol Int       Date:  2012-08-21

Review 4.  Demyelinating disorders: update on transverse myelitis.

Authors:  Chitra Krishnan; Adam I Kaplin; Carlos A Pardo; Douglas A Kerr; Sanjay C Keswani
Journal:  Curr Neurol Neurosci Rep       Date:  2006-05       Impact factor: 6.030

5.  Idiopathic transverse myelitis and neuromyelitis optica: clinical profiles, pathophysiology and therapeutic choices.

Authors:  Amer Awad; Olaf Stüve
Journal:  Curr Neuropharmacol       Date:  2011-09       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.